1832 Asset Management L.P. Cuts Stake in UnitedHealth Group Incorporated $UNH

Key Points

• 1832 Asset Management L.P. reduced its stake in UnitedHealth Group by 0.6%, owning approximately 1,228,278 shares, making it the 22nd largest position in their portfolio.
• Other large investors, like Vanguard Group and Wellington Management, have increased their holdings, with Vanguard boosting its stake by 6.6% to nearly 90.7 million shares.
• UnitedHealth Group's recent quarterly earnings report missed analysts' estimates, posting an EPS of $4.08 against expectations of $4.45, while revenues were also slightly below estimates at $111.62 billion.

1832 Asset Management L.P. cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,228,278 shares of the healthcare conglomerate's stock after selling 7,659 shares during the quarter. UnitedHealth Group makes up about 0.6% of 1832 Asset Management L.P.'s holdings, making the stock its 22nd biggest position. 1832 Asset Management L.P. owned approximately 0.14% of UnitedHealth Group worth $643,311,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group during the fourth quarter worth about $26,000. Bayforest Capital Ltd boosted its holdings in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd raised its position in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares during the period. Kapitalo Investimentos Ltda bought a new stake in UnitedHealth Group in the fourth quarter worth about $41,000. Finally, Copia Wealth Management bought a new stake in UnitedHealth Group in the fourth quarter worth about $42,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares of the company's stock, valued at $3,171,390. The trade was a 5.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.28% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several analysts have commented on UNH shares. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. Wolfe Research lowered their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. Oppenheimer lowered their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Barclays reissued an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, KeyCorp lowered their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Fifteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $365.38.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded up $3.7480 during midday trading on Friday, reaching $307.0980. 14,867,565 shares of the stock were exchanged, compared to its average volume of 23,516,492. The company's fifty day moving average is $288.39 and its 200-day moving average is $388.53. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market cap of $278.13 billion, a PE ratio of 13.31, a PEG ratio of 1.98 and a beta of 0.43. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's revenue was up 12.9% on a year-over-year basis. During the same period last year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.